Project CBD

AUGUST 6, 2019

The 29th annual International Cannabinoid Research Society ( ICRS ) symposium, which convened last month in Bethesda, Maryland, featured new developments in CBD science that have far-reaching implications for many areas of medicine. But would tolerance develop with repeated dosing, thereby mitigating CBD ’s hypotensive effect?

CBD 218

CBD Blood Pressure Research and Development Cannabinoids 218

Cannabis Law Report

NOVEMBER 22, 2019

MMJ International Holdings, the premier medical cannabis research company, announced that it has received DEA approval to ship THC and CBD from Canada. MMJ International Holdings is developing oral drug products from natural whole plant extract derivatives from the marijuana plant containing THC and CBD. 561-627-9455.

DEA 66

DEA Clinical Trials THC Research and Development 66

Project CBD

AUGUST 6, 2019

The 29th annual International Cannabinoid Research Society ( ICRS ) symposium, which convened last month in Bethesda, Maryland, featured new developments in CBD science that have far-reaching implications for many areas of medicine. But would tolerance develop with repeated dosing, thereby mitigating CBD ’s hypotensive effect?

CBD 177

CBD Blood Pressure Research and Development Cannabinoids 177

Veriheal

DECEMBER 23, 2022

Researchers Inspected Cannabis Products for Contaminants. Dr. Maxwell’s team also collected data contained in samples sourced from California. There was more inconsistency in cannabis-borne contaminant regulation as compared with other agricultural commodities,” wrote the researchers. for extracts.

Research and Development 92

Research and Development Agriculture Data Extraction 92

CannaMD

MAY 19, 2020

In a working draft of research prepared by Canadian scientists, study authors claim that their findings are “crucial for the future analysis of the effects of medical cannabis on COVID-19.” Hypothesizing that high-CBD cannabis extracts may be used to modulate ACE2 expression in COVID- 19 target tissues, researchers went to work.

Research and Development 131

Research and Development Sativa Marijuana Extraction 131

Veriheal

DECEMBER 28, 2021

Over the last few decades, the cannabis plant and its many components have been the focal point of research and stiff debate. D espite the Drug Enforcement Agency’s (DEA) announcement in May that it would soon start reviewing grower applications for research purposes, cannabis research continues to be tightly restricted.

Research and Development 98

Research and Development Chronic Pain Treatment Medicine 98

MMJ Recs

MARCH 16, 2024

With increasing acceptance of medical marijuana as a legitimate treatment option for various health conditions, the industry has attracted significant attention from investors, entrepreneurs, and policymakers alike. Additionally, stigma and misinformation surrounding medical marijuana persist, impacting public perception and patient access.

Supply Chain 105

Supply Chain Research and Development Marijuana Seed-To-Sale 105

CannaMD

AUGUST 19, 2020

The CDC notes that individuals of all ages may contract COVID-19; however, the risk of death is significantly higher for older populations and those with underlying health conditions. 3) In 2019, researchers found that CBD reduced proinflammatory cytokine production, airway inflammation, and fibrosis in a mouse model of chronic asthma.

Research and Development 141

Research and Development Marijuana Extraction Terpenes 141

The Cannigma

JUNE 15, 2021

Both THC and CBD were first isolated in a laboratory in the early 1940s by American researcher Roger Adams. It wasn’t until the 1960s, however, that Israeli researcher Raphael Mechoulam properly identified the chemical structure of CBD, which led to the wealth of knowledge and scope of research we have today. Shutterstock).

CBD 122

CBD Research and Development Epilepsy Extraction 122

Cannabis Law Report

JUNE 29, 2021

Desai brings to Ehave the ability to visualize opportunities and execute creative strategic solutions, while developing deep networks and relationships within the industry. Research in the area of mental health has been Dr. Nitin Desai’s passion. Ben Kaplan, CEO of Ehave, Inc. Forward-Looking Statement Disclaimer.

Clinical Trials 105

Clinical Trials Research and Development Data Patients 105

Greencamp

AUGUST 16, 2018

In this comprehensive guide, we are exploring the research on using cannabis for treating Amyotrophic lateral sclerosis (ALS)—a rare neuron disease that targets the motor neurons in the body. Modern science hasn’t found a cure for this condition so far, and the most frequent cause of death is respiratory failure due to muscle decay.

Strains 94

Strains Cannabinoids Research and Development Indica 94

Cannabis Law Report

JANUARY 16, 2022

But Sativex — an oromucosal spray of a formulated cannabis extract with cannabidiol (CBD) as well as THC, the psychoactive chemical component in cannabis — was taken off the Malaysian market three years later as it was not commercially viable. Sativex was developed by GW Pharmaceuticals, a maker of cannabinoid therapeutics based in Ireland.

Research and Development 98

Research and Development Pharmaceutical Epilepsy Medicine 98

Cannabis Law Report

JUNE 29, 2021

Based on 2020 data from Health Canada, approximately 37% of Canadian cannabis consumers were users of vape pens, e-cigarettes, and vapourizers 1. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. With the introduction of “Cannabis 2.0”

Concentrates 94

Concentrates Oil THC Research and Development 94

Cannabis Law Report

FEBRUARY 26, 2019

Long Beach Business Journal reports… The Long Beach Planning Commission on February 21 approved a conditional use permit for a facility to grow, test and distribute recreational cannabis in an industrial area on 15th Street, between Oregon and San Francisco avenues. We do it all.”

Recreational 45

Recreational Conditions Research and Development Cultivation 45

Cannabis Law Report

JULY 29, 2021

OTTAWA, ON , July 29, 2021 /PRNewswire/ – Tetra Bio-Pharma Inc (“Tetra” or the Company”) (TSX: TBP) (OTCQB: TBPMF) (FRA: JAM1), a leader in cannabinoid-based drug discovery and development has announced that it filed a PCT patent application for Cannabis Plant Residue and Use Thereof, PCT Patent Application No.

Research and Development 105

Research and Development Clinical Trials Events Cannabinoids 105

The Cannigma

DECEMBER 20, 2021

terpenes ) may help treat a number of different skin conditions. Researchers are still in the early stages of learning how exactly cannabinoids affect skin health, but some of the results are compelling. Some of these have been identified as possible targets for the treatment of inflammatory skin conditions.

Terpenes 133

Terpenes Cannabinoids Topical Research and Development 133

The Cannigma

MARCH 2, 2021

This issue is compounded when veterans do, on rare occasions, ask their doctors about medical marijuana, only to be treated as if they are mentally unstable or receive no specific health information at all,” the researchers found. This directly conflicts with past research claiming marijuana increases PTSD symptom severity.”.

Research and Development 143

Research and Development Treatment Chronic Pain Sleep 143

Cannabis Law Report

JULY 6, 2021

Johnson’s primary area of research expertise is the psychopharmacology of medications for treating addictions, and he is well known in the field for his discovery that topiramate, a gamma-aminobutyric acid. July 06, 2021 08:30 ET | Source: Ehave. MIAMI, July 06, 2021 (GLOBE NEWSWIRE) — Ehave, Inc., (OTC ” About Ehave, Inc.

Research and Development 97

Research and Development Wellness and Beauty Clinical Trials Therapy 97

The Cannigma

FEBRUARY 24, 2022

He began treating patients with cannabis extracts and wrote of its many clinical applications. The ECS likely developed as an evolutionary advantage to secure vertebrate survival. This isn’t at all specific to humans – data have shown a variety of responses to cannabis across other vertebrates. Bottom line.

Cannabinoids 128

Cannabinoids Research and Development Conditions Cannabis 128

Cannabis Law Report

JUNE 30, 2021

Yet, despite nearly two billion people with mental illness each year, these conditions are routinely misdiagnosed and inadequately treated. In addition, the company aims to predict what treatments are most effective in addressing these conditions, including psychedelics, which have shown tremendous promise in early clinical trials.

Treatment 52

Treatment Clinical Trials Research and Development Data 52

Cannabis Law Report

MAY 3, 2022

It is usually extracted from hemp, which is legal to farm across the United States. Delta 8 has been found to be a helpful supplement for several health conditions. Restless legs in itself does not lead to other serious health conditions. Restless leg syndrome can develop at any age, even in childhood.

Sleep 52

Sleep Research and Development Conditions Vaping 52

Otherside Farms

JULY 4, 2022

Decarboxylation of CBCa (cannabichromene carboxylic acid) from CBGa (cannabigerol acid) results in this CBC extract. In this study, researchers examined studied Bulk CBC Isolate and paw edema. The researchers studied adult mice neural stem progenitor cells (NSPCs) outside the body. The cannabinoid reduces edema. Antibacterial.

Research and Development 96

Research and Development Cannabinoids THC Concentrates 96

Greenspoon Marder Cannabis Law Group Blog

AUGUST 7, 2019

The Department of Agriculture’s Agriculture Research Service (USDA-ARS) will oversee the development and will co-locate at Cornell AgriTech. The facility currently maintains seeds and performs research and development on crops like grapes, apples, cherries and Brassica. government in the 1980s. Boor, the Ronald P.

Banking 53

Banking Hemp Research and Development Supply Chain 53

Cannabis Law Report

DECEMBER 15, 2021

Cann also owns Satipharm, a Europe-based business exclusively licensed to manufacture, develop and market the proprietary Gelpell delivery system for cannabinoids. Cann has established research and cultivation facilities in Melbourne and is developing a state-of-the-art cultivation and manufacturing facility near Mildura, Victoria.

Research and Development 52

Research and Development Pharmaceutical Compliance Compliance 52

Cannabis Law Report

AUGUST 11, 2021

Avicanna”), a biopharmaceutical company focused on the development, manufacturing, and commercialization of plant-derived cannabinoid-based products. The Branded Products include Avicanna’s proprietary cannabinoid topical formulations developed through years of extensive research by Avicanna’s team of scientists.

Topical 98

Topical Research and Development Seed-To-Sale Pharmaceutical 98

Cannabis Law Report

MARCH 9, 2022

Cann also owns Satipharm, a Europe-based business exclusively licensed to manufacture, develop and market the proprietary Gelpell delivery system for cannabinoids. Cann has established research and cultivation facilities in Melbourne and is developing a state-of-the-art cultivation and manufacturing facility near Mildura, Victoria.

Research and Development 52

Research and Development Pharmaceutical Compliance Compliance 52

Cannabis Law Report

DECEMBER 7, 2021

Adverse mental events were reported as well, however, more research should be performed to assess well this outcome. However, despite the increased use of MCs in children, there is limited data regarding their safety and efficacy in this population for those different indications 11. Data extraction. Introduction.

Safety 52

Safety Cannabinoids Events Data 52

Cannabis Law Report

JANUARY 10, 2022

Some of the health conditions included in other segments are metabolic disorders, arthritis, dermatological conditions, diabetes, cardiovascular diseases, and glaucoma. In 2020, the others segment accounted for the highest share in the market, owing to the increasing utilization of minor cannabinoids for health conditions.

Cannabinoids 52

Cannabinoids Clinical Trials Research and Development Supply Chain 52

Cannabis Info

MARCH 2, 2019

However, these chains are being repeatedly broken in many areas of the world as many scientific breakthroughs and scores of anecdotal accounts are displaying, that cannabis is a powerful medicinal tool in need of proper research and legal distribution to those in need of its healing. WHAT EXACTLY IS EPILEPSY? CONVENTIONAL TREATMENT.

Epilepsy 69

Epilepsy Treatment Marijuana Research and Development 69

Cannabis Law Report

JULY 24, 2022

According to experts, research with psychedelics (also known as hallucinogens) or related substances will increase worldwide in the coming years. Switzerland is a leader in the research and use of psychedelics in psychiatry and is considered an innovation driver in this field. Psilocybin was first extracted and identified in 1958.

Research and Development 52

Research and Development Legalization Treatment Patients 52

The Joint Blog

DECEMBER 9, 2019

The twice-daily administration of plant-derived CBD-dominant extracts is associated with symptom improvement in adolescents with autism spectrum disorder (ASD), according to observational data published in the journal Frontiers in Neurology.

CBD 49

CBD Extraction Epilepsy Sativa 49

Cannabis Law Report

JUNE 24, 2021

The antibiotic and analgesic effects & properties present in Cannabidiol, which can be used to treat a variety of ailments such as anxiety, nausea, stress, chronic pain, neurological conditions, and seizures, are likely to contribute to the growth of the market. The projections are calculated using proven research methodologies.

Research and Development 78

Research and Development Tincture Chronic Pain Pharmaceutical 78

The Joint Blog

JUNE 8, 2020

Interpret data to assess crop health and quality and adapt to growth conditions/pest management strategies. Develop and implement a costing system to accurately document and track crop production costs. Hands-on laboratory experiences will prepare you for extraction, quality assurance, and quality control roles.”

Programs 32

Programs Research and Development Environment Packaging 32

SpeedWeed

JULY 30, 2021

The CBD Insider’s 2021 US CBD Consumer Report provides some data around the CBD industry and what consumers want from CBD brands that can help savvy businesses stand out in the marketplace. Based on the data from the study, the breakdown of why U.S. A specific health condition or some other reason : 8.8%. Pets : 5.9%.

CBD 52

CBD Pets Data Research and Development 52

Greencamp

APRIL 23, 2019

According to MS Society of Canada , 1 in every 385 Canadians lives with this condition. As it’s one of the most debilitating conditions, living with multiple sclerosis is a real battle. Although they still can’t say for sure, scientists think that certain genetic and environmental factors play a role in developing MS.

Research and Development 94

Research and Development Strains Patients Treatment 94

Cannabis Law Report

DECEMBER 11, 2021

These clinics offer patients two types of medical cannabis: oil extracted from the seeds, and traditional cannabis remedies that use various parts of the plant including the leaves, roots or flowers. Department records show that the health condition of 74% of patients improves after such treatment. How effective are these proving?

Oil 52

Oil Blood Pressure Concentrates Patients 52

Cannabis Law Report

FEBRUARY 22, 2019

The initial focus of these activities Cambodia will be the securing of a license to conduct research and focused testing activities in the local environment. This research will be coordinated through consultations with the principals of InPlanta Biotechnology Inc. (“InPlanta”).

Hemp 40

Hemp Research and Development Hybrid Strains 40